中期年龄相关性黄斑变性黄斑厚度受疾病严重程度和视网膜下玻璃膜疣样沉积影响
这项纵向前瞻性研究纳入143名50岁以上无至中期AMD参与者,按影像特征分层,比较不同严重程度组的黄斑厚度。横断面分析显示,单侧大玻璃膜疣眼黄斑较对照组厚(P=0.014),伴视网膜下玻璃膜疣样沉积(SDD)眼较对照组薄(P=0.02);纵向分析中SDD眼4年内黄斑变薄更快(P=0.0058),且与基线BCVA较差和BCVA下降更快相关。
要点
- 单侧大玻璃膜疣眼中央黄斑较无大玻璃膜疣或SDD的对照眼厚(P=0.014)。
- 伴SDD眼中央黄斑较对照眼薄(P=0.02),且4年内变薄更快(P=0.0058)。
- 中央黄斑变薄更快与基线BCVA较差(P=0.016)和BCVA下降更快(P=0.0059)相关。
核心结论
- 中期AMD的黄斑厚度随疾病严重程度变化,大玻璃膜疣眼轻度增厚,SDD眼变薄。
- 中央黄斑厚度纵向评估是与功能指标相关的可及结局指标,可能适用于中期AMD干预研究。
研究设计与样本
- 纵向前瞻性研究,纳入143名50岁以上无至中期AMD参与者,采用多模态影像和功能测试随访。
- 按影像特征对中期AMD严重程度分层,横断面分析143眼,纵向分析77眼随访4年。
- 比较黄斑中心1-mm、3-mm和6-mm直径圆内的厚度,采用多变量分析。
主要发现
- 横断面多变量分析中,单侧大玻璃膜疣眼(Group 1)中央黄斑较对照眼(Group 0)厚(P=0.014)。
- 横断面多变量分析中,伴SDD眼(Group SDD)中央黄斑较对照眼薄(P=0.02)。
- 纵向分析中,SDD眼4年内黄斑变薄较对照眼更快(P=0.0058),对照眼未见显著变薄。
- 更快的中央黄斑变薄与基线BCVA较差(P=0.016)和BCVA下降更快(P=0.0059)相关。
临床怎么用
- 对中期AMD患者可考虑纵向监测中央黄斑厚度,作为与视功能相关的可及结局指标。
- 伴SDD的中期AMD眼黄斑变薄更快且视功能更差,提示需关注此类高风险眼。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate how macular thickness varies with intermediate age-related macular degeneration (iAMD) severity and the presence of subretinal drusenoid deposits (SDDs). METHODS: A longitudinal prospective study of 143 participants >50 years of age with no to intermediate AMD who were followed with multimodal imaging and functional testing. Participants were stratified by iAMD severity according to imaging features. Macular thicknesses measurements over the central circles with 1-mm, 3-mm, and 6-mm diameters obtained from ocular coherence tomography imaging were compared across severity categories using cross-sectional (143 eyes) and longitudinal (subset of 77 eyes followed for 4 years) multivariate analyses. RESULTS: Compared with control eyes without large drusen or SDDs (Group 0), central maculas of lower risk eyes with unilateral large drusen (Group 1) were thicker (P = 0.014), whereas higher risk eyes with SDDs (Group SDD) were thinner (P = 0.02) in cross-sectional multivariate analyses. In longitudinal analyses, maculas with SDDs thinned more rapidly over 4 years relative to control eyes (P = 0.0058), which did not show significant thinning. More rapid central macular thinning was associated with worse baseline best-corrected visual acuity (BCVA) (P = 0.016) and more rapid BCVA decline (P = 0.0059). CONCLUSIONS: Macular thickness in iAMD varies with disease severity, showing small increases in eyes with large drusen and decreases in eyes with SDDs. Active processes possibly related to neuroinflammation and neurodegeneration may be contributory. Longitudinal central macular thickness evaluation is an accessible outcome measure relevant to functional measures and is potentially useful for iAMD interventional studies.
引用
- Chiang TT, Keenan TD, Agrón E, et al. Macular Thickness in Intermediate Age-Related Macular Degeneration Is Influenced by Disease Severity and Subretinal Drusenoid Deposit Presence. Invest Ophthalmol Vis Sci. 2020. PMID: 32602904. doi:10.1167/iovs.61.6.59
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。